latest news releases from the newsroom
Pioneer Companies, Inc.
Olin and Pioneer Announce Pioneer Shareholder Approval
CLAYTON, Mo. and HOUSTON, Aug. 28, 2007 (PRIME NEWSWIRE) -- Olin Corporation (NYSE:OLN) and Pioneer Companies, Inc. (Nasdaq:PONR) announced today that during a special meeting of the Pioneer shareholders held earlier today, holders of a majority of the Pioneer common stock voted to approve and adopt the Agreement and Plan of Merger, dated May 20, 2007 among Olin, Princeton Merger Corp., a wholly owned subsidiary of Olin ("Merger Sub"), and Pioneer, thus approving the merger of Merger Sub with and into Pioneer. The closing of the merger is anticipated to be held on August 31, 2007.
Website Pros, Inc.
Website Pros, Web.com Set Shareholder Meetings to Approve Matters Related to Merger
JACKSONVILLE, Fla. and ATLANTA, Aug. 28, 2007 (PRIME NEWSWIRE) -- Website Pros, Inc. (Nasdaq:WSPI) and Web.com, Inc. (Nasdaq:WWWW), announced today that Web.com has scheduled a special shareholder meeting for September 25, 2007 to seek shareholder adoption of the merger agreement with Website Pros, and that Website Pros has scheduled a special shareholder meeting for the same date to seek approval of the issuance of shares of Website Pros common stock to Web.com shareholders in the transaction. The record date for both meetings is August 20, 2007.
Ceragenix Pharmaceuticals Receives Frost & Sullivan Product Innovation Award for Cerashield(TM) Coating
DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that it is the recipient of Frost & Sullivan's 2007 North American Technology Innovation Award for the field of Anti-Infective Coatings. Each year, this award is presented to a company that has demonstrated excellence in new products and technologies within its industry. Cerashield(TM) uses Ceragenix's proprietary compound that mimics the activity of a key component of the human body's innate immune system to help prevent bacterial colonization and biofilm growth on medical devices such as catheters and endotracheal tubes. Bacterial colonization and biofilm growth on medical devices can lead to serious infections which increase the patient's length of stay, results in billions of dollars in additional health care costs and are the direct cause of preventable pain, suffering and death.
PAB Bankshares, Inc.
PAB Bankshares, Inc. Announces Third Quarter 2007 Dividend
VALDOSTA, Ga., Aug. 28, 2007 (PRIME NEWSWIRE) -- On Tuesday, August 28, 2007, the Board of Directors for PAB Bankshares, Inc. (Nasdaq:PABK) approved a quarterly dividend in the amount of 14.5 cents ($0.145) per share payable on October 15, 2007 to the Company's stockholders of record on September 28, 2007. The third quarter dividend is consistent with the 14.5 cents ($0.145) per share dividend paid in the previous quarter, and it is a 3.6% increase compared to the 14 cents ($0.14) per share dividend paid for the third quarter of 2006.